期刊文献+

药物危险度评估策略及展望

Strategies and prospects of drug risk assessment
原文传递
导出
摘要 药物危险度评估是对人类暴露于药物后可能造成的身体不良反应的系统科学研究,包括药物危险鉴定、剂量-反应关系评定、药物暴露评估和药物危险度特征判定4个步骤,是一复杂又具有重要意义的挑战性工作。随着药物危险度评估中生物学机制模型的应用,生物标志物及其有效性评价工作的迅速开展,生物信息学、硅上毒理学、毒理组学等研究的广泛深入,使用动物模型替代人体进行危险度评估越来越成为可能。 Drug risk assessment is a systematic and scientific evaluation of potential adverse effects resulting from human exposures to drugs, including identification of drug risk, assessment of dose-response relationship, exposure assessment, and risk characteristics. It is a complex and significant challenging work. Accompanied by the extensive studies of bioinformatics, in silico toxicology and toxicological omics, the biological mechanism models have been used ; rapid assessments of biomarkers and their effectiveness have been carried out. Thus it has become increasingly possible to use animal models instead of human bodies in risk assessment.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第19期1856-1860,共5页 Chinese Journal of New Drugs
基金 国家"重大新药创制"科技重大专项(2008ZXJ09014-0095 2009ZX09301)
关键词 危险度评估 危险鉴定 剂量-反应关系 暴露评估 危险度特征 risk assessment risk identification dose-response relationship exposure assessment risk characteristics
  • 相关文献

参考文献24

  • 1WILLMANN JK, BRUGGEN NV, DINKELBORG LM. Molecular imaging in drug development [ J ]. Nat Rev Drug Discov, 2008, 7(7) : 591 -607.
  • 2PHILIP W. Information Resources in toxicology risk assessment [ M ]. Fourth Edition. San Diego: Academic Press, 2009:407-421.
  • 3ELSA N, GRETE T, JOHN CH, et al. Toxicological risk assessment of chemicals: a practical guide [ M ]. New York: Informa Healthcare USA, 2008:49 - 60.
  • 4SUPRATIK K, KNAL R. QSAR modeling of toxicity of diverse organic chemicals to Daphnia magna using 2D and 3D descriptors [J]. J Hazard Mater, 2010, 177(1 -3) :344-351.
  • 5PHILIP JB, WILLIAM KB, TIMOTHY JS, et al. Approaches to extrapolating animal toxicity data on organic solvents to public health [ J ]. Neurotoxicology, 2007, 28 (2) :221 - 226.
  • 6TRAVIS K, SCHNATTER R, SWAEN G, et al. A proposed framework for the integration of human and animal data in chemical risk assessment[ J]. Toxicol Lett, 2008, 180( 1 ) :19 -20.
  • 7FRANCISZEK B. Limitations to animal data on sildenafil citrate (Viagra) in the human risk assessment[ J]Fertil Steril, 2009, 92(2) :26.
  • 8彭双清,刘密凤.毒理学替代方法及其在新药安全性评价中的应用[J].毒理学杂志,2007,21(4):308-309. 被引量:8
  • 9BLAAUBOER BJ. The contribution of in vitro toxicity data in hazard and risk assessment: Current limitations and future perspectives[ J ]. Toxieol Lett, 2008, 180( 1 ) : 81 - 84.
  • 10PERSAD AS, GLINDA S. Use of epidemiologic data in integrated risk information system (IRIS) assessments[ J ]. Toxicol Appl Pharm, 2008, 233( 1 ) :137 -- 145.

二级参考文献78

  • 1胡善联.上市后药物的经济学评价[J].中国循证医学杂志,2005,5(5):353-356. 被引量:19
  • 2文镜,金宗濂.肝癌细胞能量代谢中三种酶活力的比较研究[J].北京联合大学学报,1996,10(2):19-22. 被引量:14
  • 3Calabrese EJ,Baldwin LA.Toxicology rethinks its central belief.Nature,2003,421:691-692.
  • 4Kaiser J.Hormesis.Sipping from a poisoned chalice.Science,2003,302:376-379.
  • 5Renner R.Hormesis.Nietzsche's toxicology.Sci Am,2003,289:28-30.
  • 6Calabrese EJ,Baldwin LA.Defining hormesis.Hum Exp Toxicol,2002,21:91-97.
  • 7Calabrese EJ,Baldwin LA.Hormesis:the dose-response revolution.Annu Rev Pharmacol Toxicol,2003,43:175-197.
  • 8Scientific foundation of hormesis.Introduction.Crit Rev Toxicol,2001,31:351-352.
  • 9Calabrese EJ.Overcompensation stimulation:a mechanism for hormetic effects.Crit Rev Toxicol,2001,31:425-470.
  • 10Calabrese EJ.Hormesis:from marginalization to mainstream:a case for hormesis as the default dose-response model in risk assessment.Toxicol Appl Pharmacol,2004,197:125-136.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部